CFTR modulators | Page 3 | European Cystic Fibrosis Society (ECFS)

How might cystic fibrosis care change because of telehealth and CFTR modulators

A Study Characterizing Sweat Chloride after CFTR Modulators in People with Cystic Fibrosis

Elexacaftor-Tezacaftor-Ivacaftor (ETI) improve stomach, gullet, nose and throat symptoms in people with advanced CF

Maternal Trikafta use during pregnancy and breastfeeding improved outcomes for a baby with CF

Measuring how the drug elexacaftor/tezacaftor/ivacaftor affects the muscles of breathing, using dynamic chest radiography

Restoration of the chloride and bicarbonate (soda) transport function in cystic fibrosis by Kaftrio

Use of LCI to monitor CFTR Modulator effect in people with CF

Elexacafator/tezacaftor/ivacaftor Resolves Subfertility in Females with CF: A Two Center Case Series

Pilot study suggests that the gut bacteria in people with CF change with CFTR modulator therapy

Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosis

first
previous
1
2
3
4
5
next
last